Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetyl-CoA acetyltransferase (ACAT) is an essential enzyme that catalyzes the reversible condensation of two acetyl-CoA molecules to form acetoacetyl-CoA and coenzyme A. This reaction is pivotal in the metabolic pathways for ketone body synthesis, fatty acid β-oxidation, and cholesterol/isoprenoid biosynthesis. The enzyme exists in multiple isoforms, including mitochondrial and cytosolic, encoded in humans by the ACAT1 and ACAT2 genes. Dysfunction or inherited deficiency leads to metabolic disorders such as beta-ketothiolase deficiency. As an acyltransferase, it operates at a key junction in cellular energy and lipid metabolism and is a prospective target in diseases involving metabolic dysregulation.
Competitive or allosteric inhibition/blockade of enzyme active site, preventing Claisen condensation or thiolytic cleavage of acetyl-CoA or acetoacetyl-CoA. Substrate analogs that block enzyme turnover.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetyl-CoA acetyltransferase (ACAT (commonly used for the gene family and enzyme), sometimes specified as ACAT1 for the mitochondrial isoform).